Cladis Investment Advisory, LLC Bristol Myers Squibb CO Transaction History
Cladis Investment Advisory, LLC
- $160 Billion
- Q2 2025
A detailed history of Cladis Investment Advisory, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 29,807 shares of BMY stock, worth $1.3 Million. This represents 0.86% of its overall portfolio holdings.
Number of Shares
29,807
Previous 27,807
7.19%
Holding current value
$1.3 Million
Previous $1.7 Billion
18.64%
% of portfolio
0.86%
Previous 1.23%
Shares
26 transactions
Others Institutions Holding BMY
# of Institutions
2,674Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.49 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.91 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.7 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.12 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.08 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...